Schmieder RE - Search Results

1

Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.

Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA; Symplicity HTN-2 Investigators. Esler MD, et al. Among authors: schmieder re. Circulation. 2012 Dec 18;126(25):2976-82. doi: 10.1161/CIRCULATIONAHA.112.130880. Circulation. 2012. PMID: 23248063 Free article. Clinical Trial.

2

Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.

Schlaich MP, Klingbeil AU, Jacobi J, Delles C, Schneider MP, Schmidt BM, Schmieder RE. Schlaich MP, et al. Among authors: schmieder re. J Hypertens. 2002 Jan;20(1):117-24. doi: 10.1097/00004872-200201000-00017. J Hypertens. 2002. PMID: 11791034

3

Assessment of endothelial function of the renal vasculature in human subjects.

Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE. Delles C, et al. Among authors: schmieder re. Am J Hypertens. 2002 Jan;15(1 Pt 1):3-9. doi: 10.1016/s0895-7061(01)02242-7. Am J Hypertens. 2002. PMID: 11824856 Clinical Trial.

4

Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics.

Fleischmann EH, Schlaich MP, Schmidt BM, Oehmer S, Schmieder RE. Fleischmann EH, et al. Among authors: schmieder re. Nephrol Dial Transplant. 2002 Oct;17(10):1758-65. doi: 10.1093/ndt/17.10.1758. Nephrol Dial Transplant. 2002. PMID: 12270981 Clinical Trial.

5

Rapid nongenomic effects of aldosterone on the renal vasculature in humans.

Schmidt BM, Sammer U, Fleischmann I, Schlaich M, Delles C, Schmieder RE. Schmidt BM, et al. Among authors: schmieder re. Hypertension. 2006 Apr;47(4):650-5. doi: 10.1161/01.HYP.0000205224.58715.cc. Epub 2006 Mar 6. Hypertension. 2006. PMID: 16520409 Clinical Trial.

6

Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.

Schlaich MP, Oehmer S, Schneider MP, Delles C, Schmidt BM, Schmieder RE. Schlaich MP, et al. Among authors: schmieder re. Atherosclerosis. 2007 May;192(1):155-60. doi: 10.1016/j.atherosclerosis.2006.04.025. Epub 2006 Jun 9. Atherosclerosis. 2007. PMID: 16765359 Clinical Trial.

7

Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.

Ott C, Schlaich MP, Schmidt BM, Titze SI, Schäufele T, Schmieder RE. Ott C, et al. Among authors: schmieder re. Atherosclerosis. 2008 Feb;196(2):704-11. doi: 10.1016/j.atherosclerosis.2006.12.020. Epub 2007 Feb 12. Atherosclerosis. 2008. PMID: 17298834 Clinical Trial.

8

Contribution of endothelial nitric oxide to blood pressure in humans.

Schlaich MP, Schmieder RE. Schlaich MP, et al. Among authors: schmieder re. Hypertension. 2007 May;49(5):e29; author reply e30. doi: 10.1161/HYPERTENSIONAHA.107.087536. Epub 2007 Mar 5. Hypertension. 2007. PMID: 17339534 No abstract available.

9

Renin-angiotensin system and cardiovascular risk.

Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Schmieder RE, et al. Lancet. 2007 Apr 7;369(9568):1208-19. doi: 10.1016/S0140-6736(07)60242-6. Lancet. 2007. PMID: 17416265 Review.

10

Involvement of endothelial mechanisms in L-arginine-induced alterations of renal haemodynamics in humans.

Schlaich MP, Delles C, Schmieder RE. Schlaich MP, et al. Among authors: schmieder re. J Hypertens. 2007 Jul;25(7):1515-6; author reply 1516-7. doi: 10.1097/HJH.0b013e328182d54d. J Hypertens. 2007. PMID: 17563580 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

680 results

Search Page